Zobrazeno 1 - 10
of 715
pro vyhledávání: '"Erazo T"'
Autor:
Liu SY; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Chinese Thoracic Oncology Group, Guangzhou, China., Erazo T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jee J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arfe A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gupta A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pike LRG; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Santini FC; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Daly B; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schoenfeld A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Eichholz J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Johnson K; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Martinez A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sui J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Riaz N; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chang J; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang SR; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Travis W; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Arcila ME; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Guo J; Resolution Bioscience, Exact Sciences, Kirkland, WA, USA., Gagne E; Resolution Bioscience, Exact Sciences, Kirkland, WA, USA., Garg K; Resolution Bioscience, Exact Sciences, Kirkland, WA, USA., Baehner F; Resolution Bioscience, Exact Sciences, Kirkland, WA, USA., Lee NY; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Kris MG; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scher HI; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Razavi P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gomez DR; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jones DR; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Rudin CM; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Chandarlapaty S; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Isbell JM; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA., Li BT; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medicine, Cornell University, New York, NY, USA. Electronic address: lib1@mskcc.org.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct; Vol. 210, pp. 114257. Date of Electronic Publication: 2024 Aug 14.
Autor:
Portelinha A; Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.; Department of Medicine Lymphoma Service Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., da Silva Ferreira M; Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Erazo T; Department of Medicine Lymphoma Service Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Jiang M; Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Asgari Z; Department of Medicine Lymphoma Service Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Younes A; Department of Medicine Lymphoma Service Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA. anas.younes@astrazeneca.com.; AstraZeneca, Medimmune Way, Gaithersburg, MD, USA. anas.younes@astrazeneca.com., Wendel HG; Cancer Biology & Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA. Wendelh@mskcc.org.
Publikováno v:
Nature communications [Nat Commun] 2023 Mar 18; Vol. 14 (1), pp. 1522. Date of Electronic Publication: 2023 Mar 18.
Autor:
Erazo T; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Evans CM; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pharmacology, Weill Cornell School of Medical Sciences, New York, NY, USA., Zakheim D; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chu EL; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Refermat AY; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Asgari Z; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yang X; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Da Silva Ferreira M; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mehta S; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Russo MV; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang XP; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA, 19426, USA., Chen Z; Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY, 10021, USA., Fennell M; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garippa R; Gene Editing and Screening Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Seshan V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Barbash O; Epigenetics Research Unit, GlaxoSmithKline, Collegeville, PA, 19426, USA., Batlevi CL; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leslie CS; Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melnick AM; Division of Hematology and Medical Oncology, Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Younes A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. anas.younes@astrazeneca.com., Kharas MG; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. kharasm@mskcc.org.
Publikováno v:
Nature communications [Nat Commun] 2022 Sep 27; Vol. 13 (1), pp. 5676. Date of Electronic Publication: 2022 Sep 27.
Autor:
París-Coderch L; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Soriano A; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Jiménez C; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Erazo T; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain., Muñoz-Guardiola P; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Ability Pharmaceuticals, SL, Avinguda Parc Tecnològic 3, Parc Tecnològic del Vallès, Cerdanyola, Spain., Masanas M; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Antonelli R; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Boloix A; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Alfón J; Ability Pharmaceuticals, SL, Avinguda Parc Tecnològic 3, Parc Tecnològic del Vallès, Cerdanyola, Spain., Pérez-Montoyo H; Ability Pharmaceuticals, SL, Avinguda Parc Tecnològic 3, Parc Tecnològic del Vallès, Cerdanyola, Spain., Yeste-Velasco M; Ability Pharmaceuticals, SL, Avinguda Parc Tecnològic 3, Parc Tecnològic del Vallès, Cerdanyola, Spain., Domènech C; Ability Pharmaceuticals, SL, Avinguda Parc Tecnològic 3, Parc Tecnològic del Vallès, Cerdanyola, Spain., Roma J; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain., Sánchez de Toledo J; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Pediatric Oncology and Hematology Unit, Hospital Universitari Vall D'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno L; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Pediatric Oncology and Hematology Unit, Hospital Universitari Vall D'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Lizcano JM; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain., Gallego S; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Pediatric Oncology and Hematology Unit, Hospital Universitari Vall D'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Segura MF; Translational Research in Child and Adolescent Cancer, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. miguel.segura@vhir.org.
Publikováno v:
Cell death & disease [Cell Death Dis] 2020 Sep 17; Vol. 11 (9), pp. 773. Date of Electronic Publication: 2020 Sep 17.
Autor:
López-Plana A; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain., Fernández-Nogueira P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Muñoz-Guardiola P; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Solé-Sánchez S; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Megías-Roda E; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Pérez-Montoyo H; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Jauregui P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Yeste-Velasco M; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Gómez-Ferreria M; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Erazo T; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Ametller E; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Recalde-Percaz L; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain., Moragas-Garcia N; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Noguera-Castells A; Department of Medicine, University of Barcelona, Barcelona, Spain., Mancino M; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Morán T; Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Institut Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Nadal E; Department of Medical Oncology, Thoracic Oncology Multidisciplinary Unit, Catalan Institute of Oncology, Barcelona, Spain., Alfón J; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Domènech C; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Gascon P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Lizcano JM; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Fuster G; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Department of Biochemistry & Physiology, School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.; Department of Biosciences, Faculty of Sciences and Technology, University of Vic, Vic, Spain., Bragado P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 Aug 15; Vol. 147 (4), pp. 1163-1179. Date of Electronic Publication: 2020 Feb 06.
Autor:
Elkins, J, Wang, J, Deng, X, Pattison, M, Arthur, J, Erazo, T, Gomez, N, Lizcano, J, Gray, N, Knapp, S
Publikováno v:
Journal of Medicinal Chemistry
The protein kinase ERK5 (MAPK7) is an emerging drug target for a variety of indications, in particular for cancer where it plays a key role mediating cell proliferation, survival, epithelial-mesenchymal transition, and angiogenesis. To date, no three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f7cea6bb707d70e86c9f1cea89aa43ee
http://europepmc.org/articles/PMC3683888
http://europepmc.org/articles/PMC3683888
Autor:
Muñoz-Guardiola P; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Casas J; Research Unit on BioActive Molecules (RUBAM), Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona, Barcelona, Spain; Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD) ISCII, Madrid, Spain., Megías-Roda E; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Solé S; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Perez-Montoyo H; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Yeste-Velasco M; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Erazo T; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain., Diéguez-Martínez N; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain., Espinosa-Gil S; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain., Muñoz-Pinedo C; Cell Death and Metabolism Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Yoldi G; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain., Abad JL; Research Unit on BioActive Molecules (RUBAM), Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona, Barcelona, Spain; Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD) ISCII, Madrid, Spain., Segura MF; Group of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma De Barcelona (UAB), Barcelona, Spain., Moran T; Medical Oncology Department, Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Applied Research Group in Oncology (B-ARGO), Badalona, Spain., Romeo M; Medical Oncology Department, Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Applied Research Group in Oncology (B-ARGO), Badalona, Spain., Bosch-Barrera J; Department of Medical Oncology, Catalan Institute of Oncology (ICO), Dr. Josep Trueta University Hospital and Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Oaknin A; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Alfón J; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Domènech C; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Fabriàs G; Research Unit on BioActive Molecules (RUBAM), Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona, Barcelona, Spain; Liver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD) ISCII, Madrid, Spain., Velasco G; Department of Biochemistry and Molecular Biology, School of Biology, Complutense University; Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Madrid, Spain., Lizcano JM; Protein Kinases and Signal Transduction Laboratory, Departament De Bioquímica I Biologia Molecular and Institut De Neurociències, Universitat Autònoma De Barcelona (UAB), Barcelona, Spain.
Publikováno v:
Autophagy [Autophagy] 2021 Jun; Vol. 17 (6), pp. 1349-1366. Date of Electronic Publication: 2020 May 25.
Autor:
Hackbart, Marcel1 marcel.hackbart@fh-mittelstand.de, Merz, Simon2, Graf, Niels3, Timmermanns, Stefan4
Publikováno v:
Sexuality & Culture. Dec2024, Vol. 28 Issue 6, p2581-2607. 27p.
Autor:
Zou, Dan1 (AUTHOR), Feng, Sitong1 (AUTHOR), Hu, Bowen1 (AUTHOR), Guo, Mengya1 (AUTHOR), Lv, Yan1 (AUTHOR), Ma, Rong2 (AUTHOR), Du, Yuxin2 (AUTHOR) yuxindu0408@gmail.com, Feng, Jifeng1 (AUTHOR) jifeng_feng@163.com
Publikováno v:
Cell & Bioscience. 11/23/2024, Vol. 14 Issue 1, p1-22. 22p.
Autor:
da Cruz Martinho, Diego Henrique1 (AUTHOR) diegomartinhofono@gmail.com, Lopes, Leonardo Wanderley2 (AUTHOR), Dornelas, Rodrigo3 (AUTHOR), Constantini, Ana Carolina1 (AUTHOR)
Publikováno v:
PLoS ONE. 11/14/2024, Vol. 19 Issue 11, p1-22. 22p.